Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,777 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized, Double-Blinded, Multicenter, Placebo-Controlled Trial of Shenfu Injection for Treatment of Patients with Chronic Heart Failure during the Acute Phase of Symptom Aggravation (Yang and Qi Deficiency Syndrome).
Wang X, Zhao Z, Mao J, Du T, Chen Y, Xu H, Liu N, Wang X, Wu J, Li R, Xu Y, Zhao Y, Wang L, He J, Zhang J, Zhai J, Zhao G, Hou Y, Wang S, Liu C. Wang X, et al. Among authors: du t. Evid Based Complement Alternat Med. 2019 Feb 25;2019:9297163. doi: 10.1155/2019/9297163. eCollection 2019. Evid Based Complement Alternat Med. 2019. PMID: 30930952 Free PMC article.
Efficacy of Danlou Tablet in Patients with Non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from a Multicentre, Placebo-Controlled, Randomized Trial.
Wang L, Zhao X, Mao S, Liu S, Guo X, Guo L, Du T, Yang H, Zhao F, Wu K, Cong H, Wu Y, Yang PC, Chen K, Zhang M. Wang L, et al. Among authors: du t. Evid Based Complement Alternat Med. 2016;2016:7960503. doi: 10.1155/2016/7960503. Epub 2016 Nov 8. Evid Based Complement Alternat Med. 2016. PMID: 27895696 Free PMC article.
Detection of an anti-angina therapeutic module in the effective population treated by a multi-target drug Danhong injection: a randomized trial.
Liu J, Li DD, Dong W, Liu YQ, Wu Y, Tang DX, Zhang FC, Qiu M, Hua Q, He JY, Li J, Du B, Du TH, Niu LL, Jiang XJ, Cui B, Chen JB, Wang YG, Wang HR, Yu Q, He J, Mao YL, Bin XF, Deng Y, Tian YD, Han QH, Liu DJ, Duan LQ, Zhao MJ, Zhang CY, Dai HY, Li ZH, Xiao Y, Hu YZ, Huang XY, Xing K, Jiang X, Liu CF, An J, Li FC, Tao T, Jiang JF, Yang Y, Dong YR, Zhang L, Fu G, Li Y, Huang SW, Dou LP, Sun LJ, Zhao YQ, Li J, Xia Y, Liu J, Liu F, He WJ, Li Y, Tan JC, Lin Y, Zhou YB, Yang JF, Ma GQ, Chen HJ, Liu HP, Liu ZW, Liu JX, Luo XJ, Bin XH, Yu YN, Dang HX, Li B, Teng F, Qiao WM, Zhu XL, Chen BW, Chen QG, Shen CT, Wang YY, Chen YD, Wang Z. Liu J, et al. Among authors: du th, du b. Signal Transduct Target Ther. 2021 Sep 1;6(1):329. doi: 10.1038/s41392-021-00741-x. Signal Transduct Target Ther. 2021. PMID: 34471087 Free PMC article. Clinical Trial.
1,777 results